ABIO logo

ARCA Biopharma (ABIO) Net Income

Annual Net Income

-$5.34 M
+$4.59 M+46.21%

December 31, 2023

Summary

Performance

1-Year Change

+46.21%

3-Year Change

+45.17%

5-Year Change

+32.68%

15-Year Change

+71.1%

ABIO Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$4.32 M

3-Year Low

-$19.32 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ABIO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ABIO next annual earnings announcement has not yet been scheduled

OtherABIOprofitabilitymetrics:

Annual Net Margin

-
ABIO annual net profit margin value is unknown

Annual Revenue

-
ABIO annual revenue value is unknown

Annual Gross Profit

-
ABIO annual gross profit value is unknown

Annual EPS

-$4.44
ABIO annual earnings per share is -$4.44

Quarterly Net Income

-$2.68 M
-$669.00 K-33.30%

June 30, 2024

Summary

Performance

3-Month Change

-33.3%

1-Year Change

-145.91%

3-Year Change

+43.17%

5-Year Change

+43.17%

ABIO Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$29.04 M
ABIO quarterly net profit is currently -109.22% below its historical high of $29.04 million

3-Year Low

-$5.68 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
ABIO previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
ABIO next earnings announcement has not yet been scheduled

OtherABIOprofitabilitymetrics:

Quarterly Net Margin

-
ABIO quarterly net profit margin value is unknown

Quarterly Revenue

-
ABIO quarterly revenue value is unknown

Quarterly Gross Profit

-
ABIO quarterly gross profit value is unknown

Quarterly EPS

-$2.16
ABIO quarterly earnings per share is -$2.16

TTM Net Income

-$7.20 M
-$1.20 M-19.96%

June 30, 2024

Summary

Performance

3-Month Change

-19.96%

1-Year Change

-34.86%

3-Year Change

+61.64%

5-Year Change

+61.64%

ABIO TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$5.18 M
ABIO TTM net profit is currently -239.10% below its historical high of $5.18 million

3-Year Low

-$19.32 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
ABIO previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
ABIO next earnings announcement has not yet been scheduled

OtherABIOprofitabilitymetrics:

Annual Net Margin

-
ABIO annual net profit margin value is unknown

TTM Revenue

-
ABIO TTM revenue value is unknown

TTM Gross Profit

-
ABIO TTM gross profit value is unknown

TTM EPS

-$6.00
ABIO TTM earnings per share is -$6.00

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$5.34 M
ABIO annual net profit is -$5.34 million

Annual Revenue

-
ABIO annual revenue value is unknown

Annual Cost Of Goods Sold

-
ABIO annual cost of goods sold value is unknown

Annual Operating Expenses

$7.30 M
ABIO annual total operating expenses is $7.30 million

Annual Interest Expense

-
ABIO annual interest expense value is unknown

Annual Income Tax

-
ABIO annual income tax value is unknown

ABIO Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+46.2%-145.9%-34.9%
3 y3 years+45.2%+43.2%+61.6%
5 y5 years+32.7%+43.2%+61.6%

ABIO Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+261.9%+145.9%+111.9%+34.9%+168.4%
5 y5-yearat high+261.9%+145.9%+111.9%+43.9%+168.4%
alltimeall time+23.6%+2345.3%-109.2%+2339.7%-239.1%+1713.2%

ARCA Biopharma Net Income History

DateAnnualQuarterlyTTM
Jun 2024
-
-$2.68 M(+33.3%)
-$7.20 M(+20.0%)
Mar 2024
-
-$2.01 M(+84.5%)
-$6.00 M(+12.4%)
Dec 2023
-$5.34 M(-46.2%)
-$1.09 M(-23.5%)
-$5.34 M(-1.6%)
Sep 2023
-
-$1.42 M(-3.8%)
-$5.42 M(-14.4%)
Jun 2023
-
-$1.48 M(+10.0%)
-$6.33 M(-20.8%)
Mar 2023
-
-$1.35 M(+14.7%)
-$8.00 M(-19.4%)
Dec 2022
-$9.93 M(-48.6%)
-$1.17 M(-49.7%)
-$9.93 M(-31.2%)
Sep 2022
-
-$2.33 M(-25.9%)
-$14.43 M(-14.2%)
Jun 2022
-
-$3.15 M(-3.8%)
-$16.81 M(-9.1%)
Mar 2022
-
-$3.27 M(-42.4%)
-$18.49 M(-4.3%)
Dec 2021
-$19.32 M(+98.4%)
-$5.68 M(+20.5%)
-$19.32 M(+2.9%)
Sep 2021
-
-$4.71 M(-2.5%)
-$18.77 M(+17.0%)
Jun 2021
-
-$4.83 M(+17.9%)
-$16.05 M(+28.2%)
Mar 2021
-
-$4.10 M(-20.0%)
-$12.52 M(+28.5%)
Dec 2020
-$9.74 M(+77.6%)
-$5.13 M(+157.4%)
-$9.74 M(+66.8%)
Sep 2020
-
-$1.99 M(+52.9%)
-$5.84 M(+16.7%)
Jun 2020
-
-$1.30 M(-1.4%)
-$5.00 M(-2.6%)
Mar 2020
-
-$1.32 M(+7.7%)
-$5.14 M(-6.3%)
Dec 2019
-$5.48 M(-30.9%)
-$1.23 M(+6.1%)
-$5.48 M(-4.6%)
Sep 2019
-
-$1.16 M(-19.5%)
-$5.75 M(-7.1%)
Jun 2019
-
-$1.44 M(-13.7%)
-$6.18 M(-9.9%)
Mar 2019
-
-$1.66 M(+11.8%)
-$6.86 M(-13.5%)
Dec 2018
-$7.93 M(-57.1%)
-$1.49 M(-6.5%)
-$7.93 M(-25.4%)
Sep 2018
-
-$1.59 M(-24.7%)
-$10.64 M(-21.1%)
Jun 2018
-
-$2.12 M(-22.6%)
-$13.48 M(-20.2%)
Mar 2018
-
-$2.73 M(-34.9%)
-$16.88 M(-8.6%)
Dec 2017
-$18.47 M(+12.2%)
-$4.20 M(-5.3%)
-$18.47 M(-0.3%)
Sep 2017
-
-$4.43 M(-19.7%)
-$18.53 M(-1.3%)
Jun 2017
-
-$5.52 M(+27.5%)
-$18.78 M(+9.5%)
Mar 2017
-
-$4.33 M(+1.7%)
-$17.15 M(+4.2%)
Dec 2016
-$16.46 M(+43.8%)
-$4.26 M(-9.0%)
-$16.46 M(+7.1%)
Sep 2016
-
-$4.68 M(+20.3%)
-$15.37 M(+13.8%)
Jun 2016
-
-$3.89 M(+6.8%)
-$13.51 M(+9.5%)
Mar 2016
-
-$3.64 M(+14.9%)
-$12.34 M(+7.8%)
Dec 2015
-$11.45 M(+18.1%)
-$3.17 M(+12.6%)
-$11.45 M(+5.1%)
Sep 2015
-
-$2.81 M(+3.5%)
-$10.89 M(+5.1%)
Jun 2015
-
-$2.72 M(-0.9%)
-$10.36 M(+3.1%)
Mar 2015
-
-$2.74 M(+5.1%)
-$10.04 M(+3.7%)
Dec 2014
-$9.69 M(+39.6%)
-$2.61 M(+14.3%)
-$9.69 M(-3.3%)
Sep 2014
-
-$2.28 M(-5.0%)
-$10.02 M(+5.9%)
Jun 2014
-
-$2.40 M(+0.7%)
-$9.46 M(+14.6%)
Mar 2014
-
-$2.39 M(-18.9%)
-$8.26 M(+19.0%)
Dec 2013
-$6.94 M(+60.6%)
-$2.95 M(+71.0%)
-$6.94 M(+43.6%)
Sep 2013
-
-$1.72 M(+43.7%)
-$4.83 M(+19.7%)
Jun 2013
-
-$1.20 M(+12.0%)
-$4.04 M(+1.3%)
Mar 2013
-
-$1.07 M(+27.5%)
-$3.98 M(-7.8%)
Dec 2012
-$4.32 M(-19.5%)
-$840.00 K(-9.4%)
-$4.32 M(-15.5%)
Sep 2012
-
-$927.00 K(-19.1%)
-$5.11 M(-14.9%)
Jun 2012
-
-$1.15 M(-18.6%)
-$6.00 M(+31.5%)
Mar 2012
-
-$1.41 M(-13.7%)
-$4.57 M(-14.9%)
Dec 2011
-$5.36 M(-36.3%)
-$1.63 M(-10.5%)
-$5.36 M(+0.7%)
Sep 2011
-
-$1.82 M(-719.7%)
-$5.33 M(-5.1%)
Jun 2011
-
$294.00 K(-113.3%)
-$5.61 M(-31.4%)
Mar 2011
-
-$2.21 M(+38.3%)
-$8.18 M(-2.9%)
Dec 2010
-$8.42 M
-$1.59 M(-24.3%)
-$8.42 M(-35.3%)
DateAnnualQuarterlyTTM
Sep 2010
-
-$2.11 M(-7.2%)
-$13.01 M(-14.5%)
Jun 2010
-
-$2.27 M(-7.3%)
-$15.21 M(-29.3%)
Mar 2010
-
-$2.45 M(-60.4%)
-$21.52 M(+135.5%)
Dec 2009
-$9.14 M(-53.0%)
-$6.19 M(+43.6%)
-$9.14 M(-291.4%)
Sep 2009
-
-$4.31 M(-49.8%)
$4.77 M(+746.5%)
Jun 2009
-
-$8.58 M(-186.3%)
$564.00 K(-89.1%)
Mar 2009
-
$9.93 M(+28.6%)
$5.18 M(-122.3%)
Dec 2008
-$19.43 M(+58.0%)
$7.73 M(-190.7%)
-$23.16 M(-45.5%)
Sep 2008
-
-$8.52 M(+114.8%)
-$42.53 M(-12.1%)
Jun 2008
-
-$3.96 M(-78.5%)
-$48.37 M(+214.9%)
Mar 2008
-
-$18.41 M(+58.2%)
-$15.36 M(+24.9%)
Dec 2007
-$12.30 M(-90.6%)
-$11.64 M(-19.0%)
-$12.30 M(-81.4%)
Sep 2007
-
-$14.36 M(-149.4%)
-$66.00 M(-15.7%)
Jun 2007
-
$29.04 M(-289.2%)
-$78.31 M(-38.0%)
Mar 2007
-
-$15.35 M(-76.5%)
-$126.25 M(-3.3%)
Dec 2006
-$130.55 M(+82.3%)
-$65.34 M(+145.0%)
-$130.55 M(+50.6%)
Sep 2006
-
-$26.67 M(+41.1%)
-$86.70 M(+10.5%)
Jun 2006
-
-$18.90 M(-3.8%)
-$78.49 M(+2.5%)
Mar 2006
-
-$19.65 M(-8.5%)
-$76.60 M(+7.0%)
Dec 2005
-$71.61 M(+36.4%)
-$21.48 M(+16.4%)
-$71.61 M(+13.5%)
Sep 2005
-
-$18.46 M(+8.5%)
-$63.11 M(+13.7%)
Jun 2005
-
-$17.01 M(+16.0%)
-$55.52 M(+12.2%)
Mar 2005
-
-$14.66 M(+12.9%)
-$49.47 M(-5.7%)
Dec 2004
-$52.49 M(+4.6%)
-$12.98 M(+19.4%)
-$52.49 M(+7.3%)
Sep 2004
-
-$10.87 M(-0.8%)
-$48.90 M(-0.1%)
Jun 2004
-
-$10.96 M(-38.0%)
-$48.94 M(-9.9%)
Mar 2004
-
-$17.68 M(+88.3%)
-$54.28 M(+8.2%)
Dec 2003
-$50.19 M(+11.6%)
-$9.39 M(-13.9%)
-$50.19 M(-12.4%)
Sep 2003
-
-$10.91 M(-33.1%)
-$57.31 M(+19.8%)
Jun 2003
-
-$16.31 M(+20.1%)
-$47.84 M(+20.8%)
Mar 2003
-
-$13.58 M(-17.7%)
-$39.60 M(-11.9%)
Dec 2002
-$44.98 M(+23.3%)
-$16.51 M(+1043.4%)
-$44.98 M(+12.9%)
Sep 2002
-
-$1.44 M(-82.1%)
-$39.83 M(-17.7%)
Jun 2002
-
-$8.07 M(-57.4%)
-$48.39 M(-0.7%)
Mar 2002
-
-$18.96 M(+66.9%)
-$48.75 M(+33.7%)
Dec 2001
-$36.47 M(+63.9%)
-$11.36 M(+13.5%)
-$36.47 M(+14.7%)
Sep 2001
-
-$10.01 M(+18.8%)
-$31.81 M(+22.7%)
Jun 2001
-
-$8.43 M(+26.2%)
-$25.92 M(+14.7%)
Mar 2001
-
-$6.68 M(-0.2%)
-$22.60 M(+1.6%)
Dec 2000
-$22.25 M(+20.3%)
-$6.70 M(+62.7%)
-$22.25 M(+8.2%)
Sep 2000
-
-$4.12 M(-19.5%)
-$20.56 M(-0.9%)
Jun 2000
-
-$5.11 M(-19.2%)
-$20.74 M(+3.0%)
Mar 2000
-
-$6.33 M(+26.6%)
-$20.13 M(+9.4%)
Dec 1999
-$18.50 M(+12.8%)
-$5.00 M(+16.3%)
-$18.40 M(+4.0%)
Sep 1999
-
-$4.30 M(-4.4%)
-$17.70 M(-6.3%)
Jun 1999
-
-$4.50 M(-2.2%)
-$18.90 M(+3.3%)
Mar 1999
-
-$4.60 M(+7.0%)
-$18.30 M(+11.6%)
Dec 1998
-$16.40 M(+152.3%)
-$4.30 M(-21.8%)
-$16.40 M(+20.6%)
Sep 1998
-
-$5.50 M(+41.0%)
-$13.60 M(+40.2%)
Jun 1998
-
-$3.90 M(+44.4%)
-$9.70 M(+34.7%)
Mar 1998
-
-$2.70 M(+80.0%)
-$7.20 M(+12.5%)
Dec 1997
-$6.50 M(+35.4%)
-$1.50 M(-6.3%)
-$6.40 M(+30.6%)
Sep 1997
-
-$1.60 M(+14.3%)
-$4.90 M(+48.5%)
Jun 1997
-
-$1.40 M(-26.3%)
-$3.30 M(+73.7%)
Mar 1997
-
-$1.90 M
-$1.90 M
Dec 1996
-$4.80 M
-
-

FAQ

  • What is ARCA biopharma annual net profit?
  • What is the all time high annual net income for ARCA biopharma?
  • What is ARCA biopharma annual net income year-on-year change?
  • What is ARCA biopharma quarterly net profit?
  • What is the all time high quarterly net income for ARCA biopharma?
  • What is ARCA biopharma quarterly net income year-on-year change?
  • What is ARCA biopharma TTM net profit?
  • What is the all time high TTM net income for ARCA biopharma?
  • What is ARCA biopharma TTM net income year-on-year change?

What is ARCA biopharma annual net profit?

The current annual net income of ABIO is -$5.34 M

What is the all time high annual net income for ARCA biopharma?

ARCA biopharma all-time high annual net profit is -$4.32 M

What is ARCA biopharma annual net income year-on-year change?

Over the past year, ABIO annual net profit has changed by +$4.59 M (+46.21%)

What is ARCA biopharma quarterly net profit?

The current quarterly net income of ABIO is -$2.68 M

What is the all time high quarterly net income for ARCA biopharma?

ARCA biopharma all-time high quarterly net profit is $29.04 M

What is ARCA biopharma quarterly net income year-on-year change?

Over the past year, ABIO quarterly net profit has changed by -$1.59 M (-145.91%)

What is ARCA biopharma TTM net profit?

The current TTM net income of ABIO is -$7.20 M

What is the all time high TTM net income for ARCA biopharma?

ARCA biopharma all-time high TTM net profit is $5.18 M

What is ARCA biopharma TTM net income year-on-year change?

Over the past year, ABIO TTM net profit has changed by -$1.86 M (-34.86%)